| Tag | Content |
|---|
EnhancerAtlas ID | HS187-17408 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr3:88080770-88081810 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr3:88081102-88081123 | TTTCACTTTCAGTTTCTCAGA | + | 6.21 | | IRF1 | MA0050.2 | chr3:88081096-88081117 | AATTAGTTTCACTTTCAGTTT | + | 9.51 | | IRF2 | MA0051.1 | chr3:88081095-88081113 | CAATTAGTTTCACTTTCA | - | 6.27 | | IRF8 | MA0652.1 | chr3:88081100-88081114 | AGTTTCACTTTCAG | - | 6.19 | | TFAP4 | MA0691.1 | chr3:88081178-88081188 | ATCAGCTGTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_13872 | chr3:88079079-88082202 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I088031 | chr3 | 88080321 | 88082531 |
|
Enhancer Sequence | GGTACTCAAG TAATACTTTT GAAGGAATGA AGAGCCCACA TATACAATTA TAGCATACCA 60
TTTTTATTTA AATAGCCTTC ATTGAACTCT TCTGTCTGGA ATAGTAATGG GAAAGTTCAG 120
GAGACAGGAG ATAGGGCCTG GAAGGTAGTG CAGATGGGGC TGAGTGTGAG TTTTGTCTAT 180
AAAAGGCCTC TGGCTGAGTA TGGGTGGGGA GGTTTTATAT GTCCTTGAAC ATGAGACTAG 240
GTGACTTTTA GAACAGTTGT AGATCAGATG TAAACATGCA TATGCATGCA TTCATGTTAT 300
TTCATAGGCT ATTGAGATTT TATTGCAATT AGTTTCACTT TCAGTTTCTC AGAGTGAAAG 360
GGTCTAGTTT GGCAGTGTTG CCTTAACGGG CACTGCAGCC TTACTGGCAT CAGCTGTTCA 420
ATTTAGCTCC CTTTAAACCT ATTTAACAAA GGACTAGCAT CCTATACCAA ACTTTTACAA 480
CCTTTTACCA AACCTTTTTC TGATCTGTGC CGATCAGAAG CTTTTGCTAA TTCTGCATGT 540
TTAATTCACC TGGGGTTTTT TTGCCCAGGG TTTATTTGAC AATAATTTTC TTGTTCTCAG 600
TATCTCCTCT CACTGTGATT TTCAGAACAT GATTTGGCTC CTGTCACACT CGGTGCTTTT 660
GGGGAATCTC TCCTGTTGAG TTCTACATCT TAATAACTTC CCTAGATTTT GTGTTTTGTT 720
CTTAGGGCAG CCGTGATGTA TAAATGAGCC CTTCCAATGC CTCAGTTGTT GAGCTATATG 780
ATTTTACATA TATGATTCAA TTTCCAAATC CCTCTTTGAT CTGTGAGCTC CTCAAGGCCA 840
GAGCTGTGAC TTATCCATCT TTGTATGTCC AGTATCTAGA TTACAGCCTG AAATGCTTCA 900
GGCATTCAGT AATAGCTGAA ATGAACAGAA AGAGAAGCAG AATGGGACTT GAACTTGGAA 960
GAAGTTTATT CTAATGACCA AATTTTTTCA TTCTATATGT CATATTTATT GCCAAGTTGT 1020
TTTATAGCAC TTTCTTTTCA 1040
|
